Also trades as: RENB (NASDAQ) · $vol 0M
LNAI NASDAQ
Lunai Bioworks Inc.
1W: -31.1%
1M: -44.6%
3M: -57.0%
YTD: -82.9%
1Y: -87.0%
$1.30
-0.08 (-5.80%)
Weekly Expected Move ±12.4%
$1
$1
$1
$1
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
6 relationships6
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2023-06-27
Earliest Filing
2026-03-30
Latest Filing
target: 4
acquirer: 1
investor: 1
Counterparties (Filed by LNAI)
6 relationshipsCompanies named in LNAI's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Clemann Group, SAS | — | acquirer | Company agreed to acquire blood-brain barrier delivery technology and Alzheimer's drug assets in exchange for a $20.0 mi | 2026-03-30 | View |
| Predictive Oncology Inc. | — | target | Target of Renovaro's proposed acquisition; extension agreement signed to amend LOI and acquire initial shares. | 2025-03-06 | View |
| Biosymetrics, Inc. | — | target | Target company in a merger agreement where Renovaro Acquisition Sub will merge with and into Biosymetrics. | 2025-02-28 | View |
| Predictive Oncology Inc. | POAI | target | Target company to be acquired by Renovaro in exchange for preferred stock. | 2025-01-07 | View |
| GEDi Cube Intl Ltd. | — | target | Acquired 100% of equity interests by Renovaro Biosciences Inc. | 2023-09-29 | View |
| Lincoln Park Capital Fund, LLC | — | investor | Entered into a purchase agreement and registration rights agreement to purchase up to $20,000,000 of common stock. | 2023-06-27 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-06-17 | Other Events; Exhibits | View | |
| 2026-06-16 | Other Events | View | |
| 2026-05-20 | Other Events; Exhibits | View | |
| 2026-05-13 | Shareholder Vote | View | |
| 2026-05-01 | Material Agreement; Acquisition/Disposition; Delisting Notice; Unregistered Equity Sales; Bylaws Ame | Agreement Acquisition | View |
| 2026-04-28 | Other Events; Exhibits | View | |
| 2026-03-30 | Material Agreement; Unregistered Equity Sales; Other Events; Exhibits | Agreement | View |
| 2026-03-05 | Other Events | View | |
| 2026-02-23 | Notice of Delisting or Transfer | View | |
| 2026-02-12 | Notice of Delisting or Transfer; Regulation FD Disclosure | View | |
| 2025-12-03 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-11-25 | Unregistered Sales of Equity Securities; Financial Statements and Exhibits | View | |
| 2025-11-06 | Notice of Delisting or Transfer | View | |
| 2025-11-03 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View | |
| 2025-10-30 | Notice of Delisting or Transfer | View | |
| 2025-10-16 | Notice of Delisting or Transfer; Financial Statements and Exhibits | View | |
| 2025-09-24 | Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla | View | |
| 2025-09-05 | Material Impairments; Other Events | View | |
| 2025-08-26 | Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits | View | |
| 2025-08-06 | Notice of Delisting or Transfer | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR